Nanoparticle targeting strategies for traumatic brain injury

Area of Science:

• Neural Engineering
• Nanomedicine
• Pharmacology

Background:

• Conventional treatments for neurological disorders face limitations.
• The blood-brain barrier (BBB) presents a significant challenge for drug delivery to the central nervous system.
• Traumatic brain injury (TBI) introduces further complexity to drug delivery due to its heterogeneous nature.

Purpose of the Study:

• To review nanoparticle (NP)-based drug delivery systems for targeted therapy and diagnosis of neurological disorders.
• To explore NP design considerations and functionalization strategies for precise brain and central nervous system targeting.
• To discuss challenges and potential solutions for overcoming the BBB and TBI heterogeneity.

Main Methods:

• Examination of NP physicochemical properties (size, shape, surface characteristics) and their impact on biological barrier interactions and cellular uptake.
• Analysis of various targeting ligands, including those mimicking receptor-ligand interactions, extracellular matrix components, and viral uptake mechanisms.
• Review of antibody, antibody fragments, and antibody-mimicking peptides as advanced targeting strategies.

Main Results:

• NP properties significantly influence their ability to cross biological barriers and achieve cellular uptake.
• Targeting ligands enhance NP affinity and retention in specific brain regions or cell types.
• Viral mimicry and antibody-based strategies show promise for increasing NP brain uptake.

Conclusions:

• NP-based systems offer a promising platform for targeted neurological disorder treatment, enhancing therapeutic efficacy and minimizing off-target effects.
• Understanding NP design and functionalization is crucial for developing personalized medicine approaches in neural engineering.
• Further research into advanced targeting strategies will drive innovation in treating complex brain conditions.